Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
Linda A Chamberlin, Sha-Sha Yang, Erin P McEachern, Joshua T M Lucas, Owen W McLeod Ii, Claire A Rolland, Nancy R Mack, Brielle R Ferguson and Wen-Jun Gao
The cognitive symptoms of schizophrenia (SZ) present a significant clinical burden. They are treatment resistant and are the primary predictor of functional outcomes. Although the neural mechanisms underlying these deficits remain unclear, pathological GABAergic signaling likely plays an essential role. Perturbations with parvalbumin (PV)-expressing fast-spiking (FS) interneurons in the prefrontal cortex (PFC) are consistently found in post-mortem studies of patients with SZ, as well as in animal models. Our studies have shown decreased prefrontal synaptic inhibition and PV immunostaining, along with working memory and cognitive flexibility deficits in the MK801 model. To test the hypothesized association between PV cell perturbations and impaired cognition in SZ, we activated prefrontal PV cells by using an excitatory DREADD viral vector with a PV promoter to rescue the cognitive deficits induced by adolescent MK801 administration in female rats. We found that targeted pharmacogenetic upregulation of prefrontal PV interneuron activity can restore E/I balance and improve cognition in the MK801 model. Our findings support the hypothesis that the reduced PV cell activity levels disrupt GABA transmission, resulting in the disinhibition of excitatory pyramidal cells. This disinhibition leads to an elevated prefrontal excitation/inhibition (E/I) balance that could be causal for cognitive impairments. Our study provides novel insights into the causal role of PV cells in cognitive function and has clinical implications for understanding the pathophysiology and management of SZ.
Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
Creators
Linda A Chamberlin - Drexel University
Sha-Sha Yang - Drexel University
Erin P McEachern - Drexel University
Joshua T M Lucas - Drexel University
Owen W McLeod Ii - Drexel University
Claire A Rolland - Drexel University
Nancy R Mack - Drexel University
Brielle R Ferguson - Drexel University
Wen-Jun Gao - Drexel University
Publication Details
Neuropsychopharmacology (New York, N.Y.)
Publisher
Springer Nature
Number of pages
10
Grant note
R21MH111609 / U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
R01MH085666 / U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
2016 CURE / Pennsylvania Department of Health (PDH)
Resource Type
Journal article
Language
English
Academic Unit
Neurobiology and Anatomy
Web of Science ID
WOS:000967872000002
Scopus ID
2-s2.0-85152401288
Other Identifier
991020418417804721
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: